Vijay Shreedhar
2019
In 2019, Vijay Shreedhar earned a total compensation of $1.2M as Chief Commercial Officer at Adamas Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $130,200 |
|---|---|
| Option Awards | $397,513 |
| Salary | $252,344 |
| Stock Awards | $321,063 |
| Other | $128,974 |
| Total | $1,230,094 |
Shreedhar received $397.5K in option awards, accounting for 32% of the total pay in 2019.
Shreedhar also received $130.2K in non-equity incentive plan, $252.3K in salary, $321.1K in stock awards and $129K in other compensation.
Rankings
In 2019, Vijay Shreedhar's compensation ranked 8,307th out of 13,971 executives tracked by ExecPay. In other words, Shreedhar earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,307 out of 13,971 | 41st |
Division Manufacturing | 3,283 out of 5,695 | 42nd |
Major group Chemicals And Allied Products | 1,242 out of 2,194 | 43rd |
Industry group Drugs | 1,055 out of 1,880 | 44th |
Industry Pharmaceutical Preparations | 782 out of 1,392 | 44th |
Source: SEC filing on April 23, 2020.
Shreedhar's colleagues
We found three more compensation records of executives who worked with Vijay Shreedhar at Adamas Pharmaceuticals in 2019.